Lintz Kathleen, Moynihan Clare, Steginga Suzanne, Norman Andy, Eeles Ros, Huddart Robert, Dearnaley David, Watson Maggie
Institute of Cancer Research, Sutton, England, UK.
Psychooncology. 2003 Dec;12(8):769-83. doi: 10.1002/pon.702.
While there are numerous uncertainties surrounding prostate cancer's detection and treatment, more research focusing on the psychological needs of prostate patients is required. This study investigated the support and psychological care needs of men with prostate cancer. Patients were approached during urological oncology clinics and asked to complete the: Support Care Needs Survey (SCNS), Support Care Preferences Questionnaire, EORTC QLQ-C30 (Version 3) Measure plus Prostate Module, and the Hospital Anxiety and Depression Scale (HADS). Of the 249 patients meeting study entry criteria, there was an 89% response rate resulting in a cohort of 210 patients. The data showed that significant unmet need exists across a number of domains in the areas of psychological and health system/information. The more commonly reported needs were 'fears about cancer spreading (44%),' 'concerns about the worries of those close to you (43%),' and 'changes in sexual feelings (41%).' Half of all patients reported some need in the domain of sexuality, especially men younger than 65 years. Needs were being well met in the domain of patient care and support. A significant number of patients reported having used or desiring support services, such as information about their illness, brochures about services and benefits for patients with cancer (55%), a series of talks by staff members about aspects of prostate cancer (44%), and one-on-one counselling (48%). Quality of life (QoL) was most negatively impacted in those who: were < or =65 years old, had been diagnosed within one year, or had metastatic disease. Men < or =65 had decreased social functioning, greater pain, increased sleep disturbance, and were more likely to be uncomfortable about being sexually intimate. Patients recently diagnosed had increased fatigue, more frequent urination, greater disturbance of sleep, and were more likely to have hot flushes. Those with advanced disease scored lower on 12 out of 15 QoL categories. PSA level had no effect on QoL or anxiety/depression scores. Men with advanced disease had greater levels of depression and those < or =65 years old were more likely to be anxious. Although most men with prostate cancer seem to function quite well, a substantial minority report areas of unmet need that may be targets for improving care.
虽然前列腺癌的检测和治疗存在诸多不确定性,但仍需要更多针对前列腺癌患者心理需求的研究。本研究调查了前列腺癌男性患者的支持需求和心理护理需求。在泌尿外科肿瘤门诊期间接触患者,并要求他们完成以下问卷:支持护理需求调查(SCNS)、支持护理偏好问卷、欧洲癌症研究与治疗组织生活质量核心问卷(第3版)及前列腺癌模块,以及医院焦虑抑郁量表(HADS)。在符合研究纳入标准的249名患者中,回复率为89%,最终形成了一个由210名患者组成的队列。数据显示,在心理和医疗系统/信息领域的多个方面存在着重大的未满足需求。报告较为普遍的需求包括“担心癌症扩散(44%)”、“担心身边人的忧虑(43%)”以及“性感觉变化(41%)”。所有患者中有一半表示在性方面有某种需求,尤其是65岁以下的男性。在患者护理和支持领域,需求得到了较好的满足。相当数量的患者报告使用过或希望获得支持服务,例如关于其病情的信息、针对癌症患者的服务和福利手册(55%)、工作人员关于前列腺癌各个方面的系列讲座(44%)以及一对一咨询(48%)。生活质量(QoL)在以下人群中受到的负面影响最大:年龄小于或等于65岁、确诊时间在一年以内或患有转移性疾病的患者。年龄小于或等于65岁的男性社交功能下降、疼痛加剧、睡眠障碍增加,并且在性亲密方面更容易感到不适。近期确诊的患者疲劳感增加、尿频更频繁、睡眠干扰更大,并且更有可能出现潮热。患有晚期疾病的患者在15个生活质量类别中的12个类别得分较低。前列腺特异性抗原(PSA)水平对生活质量或焦虑/抑郁评分没有影响。患有晚期疾病的男性抑郁程度更高,而年龄小于或等于65岁的男性更有可能焦虑。尽管大多数前列腺癌男性患者似乎功能良好,但仍有相当一部分人报告存在未满足的需求领域,这些领域可能是改善护理的目标。